Your browser doesn't support javascript.
loading
Association of polymorphisms in promoter region of TNF-α -238 and -308 with clinical outcomes in patients with immune-mediated inflammatory diseases on anti-TNF therapy.
Miler, Marijana; Nikolac Gabaj, Nora; Celap, Ivana; Grazio, Simeon; Tomasic, Vedran; Biscanin, Alen; Mitrovic, Josko; Derek, Lovorka; Morovic-Vergles, Jadranka; Vrkic, Nada; Stefanovic, Mario.
Afiliação
  • Miler M; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia. marijana.miler@gmail.com.
  • Nikolac Gabaj N; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
  • Celap I; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
  • Grazio S; Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
  • Tomasic V; Department for Rheumatology, Physical and Rehabilitation Medicine, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
  • Biscanin A; Department of Gastroenterology and Hepatology, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
  • Mitrovic J; Department of Gastroenterology and Hepatology, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
  • Derek L; Department of Clinical Immunology, Allergology and Rheumatology, Department of Internal Medicine, School of Medicine, University of Zagreb, University Hospital Dubrava, Zagreb, Croatia.
  • Morovic-Vergles J; Clinical Department of Laboratory Diagnostics, University Hospital Dubrava, Zagreb, Croatia.
  • Vrkic N; Division of Cl Immunology, Allergology and Rheumatology, Department of Internal Medicine, School of Medicine, University of Zagreb, University Hospital Dubrava, Zagreb, Croatia.
  • Stefanovic M; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Rheumatol Int ; 41(12): 2195-2203, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34623480
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doenças Reumáticas / Adalimumab / Infliximab / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatol Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Croácia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doenças Reumáticas / Adalimumab / Infliximab / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatol Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Croácia